Y-mAbs Therapeutics
YMAB
$15.50
Share price
5.37%
Change (1 day)
151.22%
Change (1 year)
Categories
Y-mAbs Therapeutics (YMAB) - Total debt
Total debt on the balance sheet as of December 2023 : $1.41 M
According to Y-mAbs Therapeutics 's latest financial reports the company's total debt is $1.41 M. A company’s total debt is the sum of all current and non-current debts.
Y-mAbs Therapeutics - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $1.41 M | -19.69% |
| 2022-12-31 | $1.76 M | -51.38% |
| 2021-12-31 | $3.63 M | -8.67% |
| 2020-12-31 | $3.97 M | 78.43% |
| 2019-12-31 | $2.23 M | |
| 2018-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.75 M | 93.94% | 🇺🇸 USA |